Addus HomeCare (NASDAQ:ADUS) EVP Michael Wattenbarger Sells 300 Shares of Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Michael Wattenbarger sold 300 shares of the company’s stock in a transaction that occurred on Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total transaction of $31,608.00. Following the sale, the executive vice president owned 9,444 shares in the company, valued at $995,019.84. The trade was a 3.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

Addus HomeCare Stock Down 0.5%

Addus HomeCare stock traded down $0.51 during trading on Friday, reaching $103.52. The stock had a trading volume of 14,471 shares, compared to its average volume of 233,037. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.11. Addus HomeCare Corporation has a 52-week low of $88.96 and a 52-week high of $124.43. The stock has a market cap of $1.92 billion, a PE ratio of 19.85, a P/E/G ratio of 1.49 and a beta of 0.91. The business has a 50 day moving average price of $109.41 and a 200 day moving average price of $113.01.

Institutional Investors Weigh In On Addus HomeCare

Several large investors have recently modified their holdings of the company. Global Retirement Partners LLC grew its position in shares of Addus HomeCare by 395.7% during the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after acquiring an additional 186 shares during the last quarter. Larson Financial Group LLC boosted its stake in Addus HomeCare by 133.3% during the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after purchasing an additional 136 shares during the period. Acumen Wealth Advisors LLC acquired a new stake in Addus HomeCare during the 4th quarter worth $29,000. Private Trust Co. NA grew its position in Addus HomeCare by 65.5% during the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after purchasing an additional 112 shares during the last quarter. Finally, Arax Advisory Partners increased its stake in Addus HomeCare by 95.8% in the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after purchasing an additional 137 shares during the period. 95.35% of the stock is owned by institutional investors and hedge funds.

Addus HomeCare News Roundup

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Stephens retained an “Overweight” rating on ADUS and set a $135 price target (trimmed from $140), keeping a constructive analyst opinion that supports medium-term upside. Read More.
• Positive Sentiment: Large institutional investors increased positions in recent quarters (Capital Research, Vanguard, Wasatch, State Street and others), signaling continued institutional confidence and buying power underneath the stock. Read More.
• Neutral Sentiment: Short-interest reporting is inconsistent across feeds (some entries show 0 shares, others show a material rise), creating data noise — investors should confirm with official FINRA/exchange data before sizing positions. Read More.
• Negative Sentiment: Insiders sold multiple tranches of stock on Feb. 24–25: CEO R. Dirk Allison sold several thousand shares (~7,300 across filings) and numerous EVPs also liquidated positions — concentrated insider selling often weighs on sentiment and can pressure the share price. Read More.
• Negative Sentiment: Reported short interest increased materially in February to roughly 1.15M shares (~6.5% of float, ~4.6 days to cover in mid-February) — a larger short book can amplify downside on negative headlines and increase volatility. Read More.
• Negative Sentiment: Media picked up a “pessimistic forecast” narrative tied to Stephens’ shorter-term expectations after the PT cut, which can reinforce selling pressure despite the retained Overweight rating. Read More.

Analysts Set New Price Targets

Several equities analysts recently commented on ADUS shares. Wall Street Zen raised Addus HomeCare from a “buy” rating to a “strong-buy” rating in a report on Monday. KeyCorp restated an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday. Weiss Ratings reiterated a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. BMO Capital Markets assumed coverage on shares of Addus HomeCare in a research report on Thursday, November 13th. They set a “market perform” rating and a $120.00 price objective for the company. Finally, Truist Financial set a $135.00 target price on shares of Addus HomeCare and gave the company a “buy” rating in a report on Wednesday, January 7th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $134.33.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.